Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma

Fig. 6

Identification of differentially expressed genes (DEGs) and pathway enrichment analyses in the four subgroups. a DEGs in Groups 1–3 and in Group 4. b GO analysis indicated that the majority of DEGs (based on different immunotypes) were enriched in cell surface receptor signalling pathways that regulate the immune response and in cell surface receptor signalling pathways that activate the immune response. c KEGG pathway analysis showed that the DEGs in Group 4 were enriched in elements of the WNT signalling pathway, whereas the downregulated DEGs were enriched in elements of immune-related response pathways

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us